Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
704 Leser
Artikel bewerten:
(2)

Weekend Unlimited Industries Inc.: Weekend Unlimited Executes LOI to Acquire 100% of the Intellectual Property of Award-Winning Oklahoma Cannabis Brand Ruby Mae's

Finanznachrichten News

VANCOUVER, BC / ACCESSWIRE / June 24, 2020 / Weekend Unlimited Industries Inc. ("Weekend" or the "Company") (CSE:POT)(FSE:0OS2)(OTCQB:WKULF) is pleased to announce the execution of a non-binding Letter of Intent, dated June 21, 2020, to acquire 100% of Ruby Mae's, LLC ("Ruby Mae's) intellectual property, including trademarks, copyrights, trade secrets, inventions and know-how (the "Intellectual Property").

Weekend's brand alliance and licensing agreement with Ruby Mae's announced on September 17th, 2019, accelerated both the WKND! and Orchard Heights market entry and reach in Oklahoma. The proposed acquisition of the Ruby Mae's brand will further accelerate the Weekend's brand recognition within Oklahoma and substantially expand Weekend's lineup of brands, products, and sales.

"The proposed acquisition of the iconic Oklahoma-based brand is a significant milestone for the Company. With a presence in over 350 dispensaries, combining both Ruby Maes and Weekend Unlimited brands will add exceptional traction to our growth in the Oklahoma medical cannabis market," said Chris Backus, CEO of Weekend. "Together we intend to continue the expansion of new innovative products while simultaneously increasing the sales and exposure of our existing portfolio."

Pursuant to the terms of the LOI, the Weekend shall acquire the Intellectual Property in exchange for USD$2,000,000, which shall consist of USD$500,000 in cash and USD$1,500,000 in shares of the Weekend. At closing, Ruby Mae's shall receive USD$200,000 in cash and USD$800,000 of shares with the remaining shares and cash being paid out over a period of 24 months from closing. In addition, the vendors shall be eligible for bonus shares of the Company vesting over a period of two years from closing and based on specific revenue targets being achieved and entry into additional U.S. states. At closing, the Weekend shall enter into a licensing agreement with the vendors for use of the Ruby Mae's brand in consideration for a licensing fee and the Ruby Mae's Co-founders will be granted 2 board seats of Weekend.

During the period from April 1, 2020, to June 18, 2020, Ruby Mae's branded products received purchase orders for in aggregate USD$700,923, generating USD$414,127 in revenue (the difference of $286,796 awaiting delivery) with a gross profit of 33%. Additionally, from April to May 2020, Ruby Mae's demonstrated revenue growth by 74% month-over-month, while increasing gross profit by 63%.

Travis Hunter, CEO, and Founder of Ruby Mae's added, "We believe that the Weekend is the right home for the Ruby Mae's brand at this point in time to go along with the WKND! and Orchard Heights brands. The Weekend will provide the Ruby Mae's brand with the resources and capabilities to rapidly grow the company and will permit the brand to continually and aggressively gain market share in the Oklahoma cannabis market."

The completion of the acquisition remains subject to completion of due diligence and execution of final binding definitive documentation, which is expected to be completed within 30 days of the date of the LOI. There can be no assurances that the completion of the acquisition will occur on the terms set forth above or at all. In accordance with Oklahoma regulations and legislation, neither the Company, nor its subsidiary, shall acquire any interest in regulated inventory or licenses related to the cultivation, manufacture, distribution, or sale of cannabis or cannabis-related products in connection with the transaction. The final terms and conditions of the transaction will be outlined at the execution of an asset purchase agreement and a licensing agreement.

About Ruby Maes

Located in Bixby, Oklahoma, Ruby Mae's is one of Oklahoma's most recognizable cannabis brands. Ruby Mae's products currently include premium, award-winning medical cannabis edibles and pre-rolls. Learn more at https://www.rubymaes.com/

About Weekend Unlimited Industries Inc.

Weekend Unlimited is a lifestyle-based cannabis and CBD wellness company. We are developing and launching premium cannabis and CBD brands to deliver life's highs - any- time, anywhere. Our CBD products are available online and at a retailer near you. Weekend Unlimited is well-positioned to launch and scale the brands that will define cannabis and CBD. Learn more at www.weekendunlimited.com

For further information, please contact:

Mr. Chris Backus, President & CEO, Director Telephone: 1(236) 317-2812
E-mail: IR@weekendunlimited.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward- looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking infor- mation reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates" or "believes" or variations (including negative variations) of such words and phrases or may be identified by state- ments to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward- looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic condi- tions, industry conditions and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new in- formation, future events, or otherwise, except as required by securities laws.

SOURCE: Weekend Unlimited Industries Inc.



View source version on accesswire.com:
https://www.accesswire.com/595018/Weekend-Unlimited-Executes-LOI-to-Acquire-100-of-the-Intellectual-Property-of-Award-Winning-Oklahoma-Cannabis-Brand-Ruby-Maes

© 2020 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.